Companies / BOC Sciences / Vanucizumab
BOC Sciences

Vanucizumab | BOC Sciences

Vanucizumab is a bispecific IgG1-like monoclonal antibody that blocks Angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF-A).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.